WINDTREE THERAPEUTICS INC /DE/ Marketable Securities, Unrealized Gain (Loss)
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Marketable Securities, Unrealized Gain (Loss) of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-04-03.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2020-04-03
- WINDTREE THERAPEUTICS INC /DE/ marketable securities, unrealized gain (loss) for the quarter ending 2019-12-31 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ marketable securities, unrealized gain (loss) for the quarter ending 2019-09-30 was -$12.00K.
- WINDTREE THERAPEUTICS INC /DE/ marketable securities, unrealized gain (loss) for the quarter ending 2019-06-30 was -$28.00K.
- WINDTREE THERAPEUTICS INC /DE/ marketable securities, unrealized gain (loss) for the quarter ending 2019-03-31 was $40.00K.
- WINDTREE THERAPEUTICS INC /DE/ marketable securities, unrealized gain (loss) for fiscal 2019 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ marketable securities, unrealized gain (loss) for fiscal 2018 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ marketable securities, unrealized gain (loss) for fiscal 2017 was $0.00.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | -$12.00K derived: sum of 2 quarters · filed 2020-04-03 | -$40.00K derived: sum of 3 quarters · filed 2020-04-03 | $0.00 10-K · filed 2020-04-03 |
| 2019-09-30 | -$12.00K 10-Q · filed 2019-11-14 | -$40.00K derived: sum of 2 quarters · filed 2019-11-14 | $0.00 10-Q · filed 2019-11-14 | $0.00 derived: sum of 4 quarters · filed 2020-04-03 |
| 2019-06-30 | -$28.00K 10-Q · filed 2019-08-14 | $12.00K 10-Q · filed 2019-08-14 | $12.00K derived: sum of 3 quarters · filed 2020-04-03 | $12.00K derived: sum of 4 quarters · filed 2020-04-03 |
| 2019-03-31 | $40.00K 10-Q · filed 2019-05-20 | $40.00K derived: sum of 2 quarters · filed 2020-04-03 | $40.00K derived: sum of 3 quarters · filed 2020-04-03 | $40.00K derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | $0.00 derived: sum of 2 quarters · filed 2020-04-03 | $0.00 derived: sum of 3 quarters · filed 2020-04-03 | $0.00 10-K · filed 2020-04-03 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $0.00 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-14 | $0.00 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-20 | |||
| 2017-12-31 | $0.00 10-K/A · filed 2019-04-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |